DXCM Financial Facts

Total cost of sales: 21.8M
Total operating expenses: 52.2M
See Full Income Statement

Total current liabilities: 40.6M
Total liabilities and stockholders' equity: 159.4M
See Full Balance Sheet

DexCom, Inc. (DXCM) Earnings

  |   Expand Research on DXCM
Next EPS Date 2/20/15 *Est. EPS Growth Rate +22.2% *Last Qtr.
Average EPS % Beat Rate -16.6% Revenue Growth Rate +60.8% *Last Qtr.
Average % Move 1-Wk after EPS +8.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/6/14 Q314 -$0.07-$0.06 -$0.01$69M$60.2M N/A Details
8/6/14 Q214 -$0.08-$0.10 +$0.02$58.8M$52.45M N/A Details
5/1/14 Q114 -$0.17-$0.08 -$0.09$46.7M$44.15M N/A Details
2/20/14 Q413 -$0.04-$0.07 +$0.03$51.3M$48.53M N/A Details
11/6/13 Q313 -$0.09-$0.13 +$0.04$42.9M$35.9M N/A Details
8/7/13 Q213 -$0.14-$0.16 +$0.02$35.5M$31.14M N/A Details
5/1/13 Q113 -$0.16-$0.17 +$0.01$29.6M$28.33M N/A Details
2/21/13 Q412 -$0.12-$0.16 +$0.04$33.3M$31.09M N/A Details